
Written based on 8 research studies on PubMed, searched on 11 Nov 2026.
The claim
Posts online say that ivermectin helps with ovarian cancer.
Where research stands
We found 8 published papers on ivermectin and ovarian cancer. They were published between 2005 and 2024. 1 of them is a study in people. None of them compared people who got it with a group that did not. 3 were studies in animals, and 4 were only in cells in the lab.
- 1In people
- 3In animals
- 4Only in the lab
What the studies found
We have not summed up these studies in words yet. The most important papers are listed under Sources.
Verdict
Ivermectin has been studied in people with ovarian cancer, but not in randomised trials.
What this means for you: A study in people is not proof that it helps you. Do not stop or change your medicines because of it. Ask your doctor before you start taking it.
Sources
- Evidence for macrofilaricidal activity of ivermectin against female Onchocerca volvulus: further analysis of a clinical trial in the Republic of Cameroon indicating two distinct killing mechanisms.2005 · Parasitology · Study in people
- Pharmacoproteomics reveals energy metabolism pathways as therapeutic targets of ivermectin in ovarian cancer toward 3P medical approaches.2024 · EPMA J · In animals
- Ivermectin Augments the In Vitro and In Vivo Efficacy of Cisplatin in Epithelial Ovarian Cancer by Suppressing Akt/mTOR Signaling.2020 · Am J Med Sci · In animals
- Ivermectin inactivates the kinase PAK1 and blocks the PAK1-dependent growth of human ovarian cancer and NF2 tumor cell lines.2009 · Drug Discov Ther · In animals
- Ivermectin Augments the Anti-Cancer Activity of Pitavastatin in Ovarian Cancer Cells.2023 · Diseases · In the lab
- SILAC quantitative proteomics analysis of ivermectin-related proteomic profiling and molecular network alterations in human ovarian cancer cells.2021 · J Mass Spectrom · In the lab
- Quantitative proteomics revealed energy metabolism pathway alterations in human epithelial ovarian carcinoma and their regulation by the antiparasite drug ivermectin: data interpretation in the context of 3P medicine.2020 · EPMA J · In the lab
- Anti-parasite drug ivermectin can suppress ovarian cancer by regulating lncRNA-EIF4A3-mRNA axes.2020 · EPMA J · In the lab


